Concepedia

Afsaneh Lavasanifar

AL

Statistics

Publications

138

Citations

8.5K

H-Index

51

Active since

1997

Affiliations

University of Alberta(Current)

King Saud University

Tabriz University of Medical Sciences

Isfahan University of Medical Sciences

University of Wisconsin–Madison

Afsaneh Lavasanifar is an author at University of Alberta specializing in drug delivery, pharmacy, and pharmaceutics.

ORCID

Publications per year

1997–2024

138

Publications

138

The Uniqueness of Albumin as a Carrier in Nanodrug Delivery

Alessandra Spada, Jaber Emami, Jack A. Tuszyński et al. · Molecular Pharmaceutics · 2021 · 561 citations

, , +17

Traceable Multifunctional Micellar Nanocarriers for Cancer-Targeted Co-delivery of MDR-1 siRNA and Doxorubicin

Xiao-Bing Xiong, Afsaneh Lavasanifar · ACS Nano · 2011 · 408 citations

, , +17

Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity

Samar Hamdy, Ommoleila Molavi, Zengshuan Ma et al. · Vaccine · 2008 · 249 citations

, , +14

Mitochondrial Delivery of Doxorubicin via Triphenylphosphine Modification for Overcoming Drug Resistance in MDA-MB-435/DOX Cells

Min Han, Mohammad Reza Vakili, Hoda Soleymani Abyaneh et al. · Molecular Pharmaceutics · 2014 · 219 citations

, , +17

Micelles of methoxy poly(ethylene oxide)-b-poly(ɛ-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A

Hamidreza Montazeri Aliabadi, Abdullah Mahmud, Annahita Dehmoobed Sharifabadi et al. · Journal of Controlled Release · 2005 · 210 citations

, , +16

1–5 of 138